SCHEMBL14601007

SCHEMBL14601007

CCc1nn(-c2ncccc2C)c(Nc2ccc(C(F)(F)F)cc2C(=O)O)c1-c1cccnc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA1 P30542 11/20 0.48
DHODH Q02127 3/20 0.42
ADORA2B P29275 1/20 0.41
SORT1 Q99523 1/20 0.39
TAS2R14 Q9NYV8 1/20 0.39
ADORA3 P0DMS8 1/20 0.37
LRRK2 Q5S007 1/20 0.36
MEN1 O00255 1/20 0.36
GMNN O75496 1/20 0.36
ALDH1A1 P00352 1/20 0.36
LMNA P02545 1/20 0.36
TTR P02766 1/20 0.36
CYP1A2 P05177 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2C9 P11712 1/20 0.36
PKM P14618 1/20 0.36
NFKB1 P19838 1/20 0.36
UGT1A1 P22309 1/20 0.36
PTGS1 P23219 1/20 0.36
PTGS2 P35354 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4666215 0.90 ADORA1 (0.51) ADORA1DHODHADORA3
SCHEMBL14600708 0.89 ADORA1 (0.50) ADORA1DHODHADORA2BADORA3LMNA
SCHEMBL14600233 0.89 ADORA1 (0.46) ADORA1DHODHADORA2BADORA3
SCHEMBL14600441 0.83 ADORA1 (0.56) ADORA1DHODHADORA2BADORA3
SCHEMBL14600440 0.82 ADORA1 (0.50) ADORA1DHODHADORA2BADORA3
SCHEMBL14600205 0.81 ADORA1 (0.49) ADORA1DHODHADORA2BADORA3
SCHEMBL14600241 0.81 ADORA1 (0.46) ADORA1DHODHADORA2BADORA3
SCHEMBL14600996 0.80 ADORA1 (0.51) ADORA1ADORA2BMEN1KMT2A
SCHEMBL4665259 0.80 ADORA1 (0.51) ADORA1DHODHADORA2BADORA3
SCHEMBL14600230 0.80 ADORA1 (0.47) ADORA1DHODHADORA2BADORA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007027842-A1 ANILINOPYRAZOLE DERIVATIVES USEFUL FOR THE TREATMENT OF DIABETES BAYER HEALTHCARE LLC (US) 2007-03-08 WO disclosed